The role of osteopontin in d-galactosamine-induced liver injury in genetically obese mice - PubMed (original) (raw)
. 2010 Feb 1;242(3):344-51.
doi: 10.1016/j.taap.2009.11.006. Epub 2009 Nov 11.
Affiliations
- PMID: 19913045
- DOI: 10.1016/j.taap.2009.11.006
The role of osteopontin in d-galactosamine-induced liver injury in genetically obese mice
Hyo-Jung Kwon et al. Toxicol Appl Pharmacol. 2010.
Abstract
Various epidemiological studies have shown that obesity increases the risk of liver disease, but the precise mechanisms through which this occurs are poorly understood. In the present study, we hypothesized that osteopontin (OPN), an extracellular matrix and proinflammatory cytokine, has an important role in making obese mice more susceptible to inflammatory liver injury. After exposure of genetically obese ob/ob and db/db mice to a single dose of d-galactosamine (GalN), the plasma liver enzyme levels, histology and expression levels of cytokines and OPN were evaluated. The ob/ob and db/db mice, which were more sensitive to GalN-induced inflammatory liver injury compared with wild-type mice, had significantly higher plasma and hepatic OPN expression levels. Increased OPN expression was mainly found in hepatocytes and inflammatory cells and was correlated with markedly up-regulated interleukin (IL)-12 and IL-18 levels. Furthermore, pretreatment with a neutralizing OPN (nOPN) antibody attenuated the GalN-induced inflammatory liver injury in ob/ob and db/db mice, which was accompanied by significantly reduced macrophages recruitment and IL-12 and IL-18 productions. Taken together, these results suggest that up-regulated OPN expression is a contributing factor to increased susceptibility of genetically obese mice to GalN-induced liver injury by promoting inflammation and modulating immune response.
Copyright 2009 Elsevier B.V. All rights reserved.
Similar articles
- Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin.
Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF. Sahai A, et al. Am J Physiol Gastrointest Liver Physiol. 2004 Nov;287(5):G1035-43. doi: 10.1152/ajpgi.00199.2004. Epub 2004 Jul 15. Am J Physiol Gastrointest Liver Physiol. 2004. PMID: 15256362 - Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
Wan JY, Gong X, Zhang L, Li HZ, Zhou YF, Zhou QX. Wan JY, et al. Eur J Pharmacol. 2008 Jun 10;587(1-3):302-8. doi: 10.1016/j.ejphar.2008.02.081. Epub 2008 Mar 7. Eur J Pharmacol. 2008. PMID: 18420187 - Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages.
Shimizu S, Okuda N, Kato N, Rittling SR, Okawa A, Shinomiya K, Muneta T, Denhardt DT, Noda M, Tsuji K, Asou Y. Shimizu S, et al. Arthritis Rheum. 2010 May;62(5):1329-37. doi: 10.1002/art.27400. Arthritis Rheum. 2010. PMID: 20155835 - Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer.
Ramaiah SK, Rittling S. Ramaiah SK, et al. Toxicol Sci. 2008 May;103(1):4-13. doi: 10.1093/toxsci/kfm246. Epub 2007 Sep 22. Toxicol Sci. 2008. PMID: 17890765 Review. - Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury.
Ramaiah SK, Rittling S. Ramaiah SK, et al. Expert Opin Drug Metab Toxicol. 2007 Aug;3(4):519-26. doi: 10.1517/17425225.3.4.519. Expert Opin Drug Metab Toxicol. 2007. PMID: 17696803 Review.
Cited by
- TSH-SPP1/TRβ-TSH positive feedback loop mediates fat deposition of hepatocyte: Crosstalk between thyroid and liver.
Huang B, Wen W, Ye S. Huang B, et al. Front Immunol. 2022 Oct 10;13:1009912. doi: 10.3389/fimmu.2022.1009912. eCollection 2022. Front Immunol. 2022. PMID: 36300106 Free PMC article. - Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis.
Filip R, Radzki RP, Bieńko M. Filip R, et al. Clin Interv Aging. 2018 Oct 4;13:1879-1891. doi: 10.2147/CIA.S170533. eCollection 2018. Clin Interv Aging. 2018. PMID: 30323574 Free PMC article. Review. - Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.
Kahles F, Findeisen HM, Bruemmer D. Kahles F, et al. Mol Metab. 2014 Mar 22;3(4):384-93. doi: 10.1016/j.molmet.2014.03.004. eCollection 2014 Jul. Mol Metab. 2014. PMID: 24944898 Free PMC article. Review. - Alterations in osteopontin modify muscle size in females in both humans and mice.
Hoffman EP, Gordish-Dressman H, McLane VD, Devaney JM, Thompson PD, Visich P, Gordon PM, Pescatello LS, Zoeller RF, Moyna NM, Angelopoulos TJ, Pegoraro E, Cox GA, Clarkson PM. Hoffman EP, et al. Med Sci Sports Exerc. 2013 Jun;45(6):1060-8. doi: 10.1249/MSS.0b013e31828093c1. Med Sci Sports Exerc. 2013. PMID: 23274598 Free PMC article. - Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis.
Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ. Tanaka N, et al. Hepatology. 2012 Jul;56(1):118-29. doi: 10.1002/hep.25630. Epub 2012 Jun 6. Hepatology. 2012. PMID: 22290395 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous